Optometrists in Chesaning, MI Accepting Medicare
8 Optometrists found. Showing 1 - 8
 Aeg Michigan Professional Llc Optometrist Medicare: Medicare Enrolled Practice Location: 1555 Brady St, Chesaning, MI 48616 Phone: 989-845-7050 Fax: 314-741-4947 |
Robert & William Hass Optometrists Professional Corp Optometrist Medicare: Medicare Enrolled Practice Location: 1180 W Broad St, Chesaning, MI 48616 Phone: 989-845-3835 Fax: 989-845-3982 |
Advanced Eyecare & Contact Lens Center Optometrist Medicare: Medicare Enrolled Practice Location: 1555 Brady Road, Chesaning, MI 48616 Phone: 989-845-7050 Fax: 989-845-2036 |
Advanced Eyecare & Contact Lens Center Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1555 Brady Road, Chesaning, MI 48616 Phone: 989-845-7050 Fax: 989-845-2036 |
 Dr. David Eric Duryea, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1555 Brady Road, Chesaning, MI 48616 Phone: 989-845-7050 Fax: 989-845-2036 |
 Dr. Autumn Kay Wicke, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1555 Brady Road, Chesaning, MI 48616 Phone: 989-845-7050 Fax: 989-845-2036 |
Dr. Theodore James Billy, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1555 Brady Road, Chesaning, MI 48616 Phone: 989-845-7050 Fax: 989-845-2036 |
Dr. William B Hass, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1180 W Broad St, Chesaning, MI 48616 Phone: 989-845-3835 Fax: 989-845-3982 |
News Archive
DC Devices announces completion of enrollment in REDUCE LAP-HF trial for diastolic heart failure treatment
DC Devices, Inc., a medical device company pioneering first-in-class structural heart devices for heart failure, today announced that it has completed enrollment and implants in the REDUCE LAP-HF trial, an open label, multi-center, single-arm study of the InterAtrial Shunt Device (IASD) – the world's first transcatheter device for the treatment of diastolic heart failure (DHF), which is also known as heart failure with preserved ejection fraction (HFpEF).
Post-2015 development agenda must address global health
"A proliferation of complex challenges to development, such as political conflict, economic austerity, and environmental degradation, all demand attention, but should not deflect from recognizing that good health is central to advancing global prosperity," GAVI Alliance CEO Seth Berkley, WHO Director-General Margaret Chan, Global Fund to Fight AIDS, TB and Malaria Executive Director Mark Dybul, World Bank Sector Manager for Health in Latin America Keith Hansen, UNICEF Executive Director Anthony Lake, UNFPA Executive Director Babatunde Osotimehin, and UNAIDS Executive Director Michel Sidibé, write in a Lancet opinion piece examining the post-2015 development agenda.
Consuming high amounts of sugar could increase heart disease risk in healthy people
Healthy people who consume high levels of sugar are at an increased risk of developing cardiovascular disease.
Teva announces new data from women's health franchise
Teva Women's Health today announced new data from the Company's expanding women's health franchise will be featured at the 60th Annual Clinical Meeting of the American Congress of Obstetricians and Gynecologists (ACOG) in San Diego, California, May 5-9, 2012.
Quorum sensing data presented at the North American Cystic Fibrosis Conference by Neem Biotech
Neem Biotech, the Welsh-based fundamental Research and Development arm of the Zaluvida group of life science companies, was pleased to present the work into development of a novel mode of action as an adjunct to existing antibiotics at the North American Cystic Fibrosis Conference Indiana, USA from 2nd November 2017 to 4th of November 2017.
› Verified 2 days ago